biotechScienceA Billionaire-Backed Startup Wants to Grow 'Organ Sacks' to Replace Animal TestingBy Emily MullinScienceJapan Approves the World’s First Treatment Made With Reprogrammed Human CellsBy Ritsuko KawaiScienceThis Chinese Startup Wants to Build a New Brain-Computer Interface—No Implant RequiredBy Emily MullinScienceCrispr Pioneer Launches Startup to Make Tailored Gene-Editing TreatmentsBy Emily MullinScienceFormer Neuralink Exec Launches Organ Preservation EffortBy Emily MullinScienceParadromics Gets FDA Approval to Trial Its Brain Implant in PeopleBy Emily MullinScienceA Gene-Editing Therapy Cut Cholesterol Levels by HalfBy Emily MullinScienceA New Light-Based Cancer Treatment Kills Tumor Cells and Spares Healthy OnesBy Javier CarbajalScienceA New Startup Wants to Edit Human EmbryosBy Emily MullinJona’s Mail-Order Kit Helps You Decode Your MicrobiomeBy Brent RoseScienceScientist Who Was Offline 'Living His Best Life' Stunned by Nobel Prize WinBy Louise MatsakisScienceThe Next Era of Gene Editing Will Be Disease AgnosticBy Emily MullinScienceCrispr Offers New Hope for Treating DiabetesBy Javier CarbajalScienceResearchers Create 3D-Printed Artificial Skin That Allows Blood CirculationBy Ritsuko KawaiScienceNeuralink’s Bid to Trademark ‘Telepathy’ and ‘Telekinesis’ Faces Legal IssuesBy Emily MullinScienceChina Is Building a Brain-Computer Interface IndustryBy Emily MullinScienceRFK Jr. Is Supporting mRNA Research—Just Not for VaccinesBy Emily MullinThe Big StoryWhere Are All the AI Drugs?By Veronique GreenwoodScienceEli Lilly’s Obesity Pill Appears to Work as Well as Injected GLP-1sBy Emily MullinScienceA New Obesity Pill May Burn Fat Without Suppressing AppetiteBy Emily MullinScienceCongress Demands Answers on Data Privacy Ahead of 23andMe SaleBy Emily MullinScienceA Neuralink Rival Just Tested a Brain Implant in a PersonBy Emily MullinScienceA Baby Received a Custom Crispr Treatment in Record TimeBy Emily MullinScienceAn Experimental Obesity Pill Mimics Gastric Bypass SurgeryBy Emily MullinMore Stories
